Untitled - Localite

F r i d a y 1 1 th D e c e m b e r , 2 0 1 5
12:30-01:30 pm Welcome (coffee and drinks, no lunch!)
01:30-02:00 pm Introduction: Dean Faculty Medicine University Ghent
G. Vanderstraeten (Belgium)
Part IA • Moderated by C. Baeken (Belgium) & E. Poulet (France)
02:00-02:45 pm Current European guidelines for rTMS: focus on Psychiatry - Key note
J.P. Lefaucheur (France)
Part IIA • Moderated by E. Haffen (France) & U. Palm (Germany)
02:45-03:15 pm Major Depression: Current position of rTMS in the treatment algorithm for Major Depression:
After or before ECT?
P.Sienaert (Belgium) & K. Ebmeier (UK)
03:15-03:45 pm NIBS in treatment resistant depression algorithms: how defining good candidates?
B. Langguth (Germany)
03:45-04:15 pm Network effects of (r)TMS: from theory to the clinic
A. Sack (The Netherlands)
04:15-04:45 pm Coffee break and poster session
Part
II B • Moderated by J. Horacek (Czech Republic) & R. Zaman (UK)
04:45-05:15 pm Schizophrenia: Auditory Hallucinations: rTMS yes or no?
A. Aleman (The Netherlands) & R. Jardri (France)
05:15-05:45 pm Neuronavigation in clinical practice: useful or not?
M. Arns (The Netherlands) & F. Rachid (Switzerland)
05:45-06:30 pm Results of an intended European survey: debate on the practical aspects of rTMS in Europa
ROUND TABLE moderated by F. Haesebaert & M. Bubrovszky (France)
06:30 pm Cocktails and tapas parallel with the poster session
Best poster price for 200 € - Runners up 2 and 3 each 150 €.
The scientific committee will be the jury members.
The winner(s) will be rewarded with their price the following day.
S a t u r d a y 1 2 th D e c e m b e r .
08:30-09:00 am Welcome coffee and cake
Part
I • Moderated by B. Millet (France) - C. Bervoets (Belgium)
09:00-09:45 am Communication TBC - J. Downar (Canada)
09:45-10:30 am rTMS from research to clinical practice - B.M. Dell’Osso (Italy)
10:30-11:00 am Coffee break
Part
II • Moderated by A. Aleman (The Netherlands) & J. Brunelin (France/Canada)
11:00 am -12:30 pm Free communication sessions
Interested European NIBS researchers and clinicians can propose a topic to orally present (15 mn : 10‘+ 5 Q/A).
6 communications will be selected by the scientific committee.
Those topics that were not chosen may be presented as a poster (after agreement of the committee).
12:30-02:00 pm Sandwich Lunch
Part
III • Moderated by B. Langguth (Germany) & K. Ebmeier (UK)
02:00-02:30 pm Modulation of executive functions by NIBS - Perspetives for targeted interventions
C. Plewnia (Germany) - TBC
02:30-03:00 pm TDCS for depressive disorders
A. Brunoni (Brazil)
03:00-03:30 pm NIBS in schizophrenia: State-of the art on neurobiological findings
J. Horacek (Czech Republic)
Part IV • Moderated by C. Baeken (Belgium) & E. Poulet (France)
03:30-04:00 pm Avenues of coordinated translational research on NIBS in Europe:
First experiences from a German multisite project
F. Padberg (Germany)
04:00-05:00 pm Towards a European network - ROUND TABLE
05:00 pm
End of the meeting. Rounding up speech and farewell